| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | -0.021 | 0.7 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.023 | 0.7 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | Pazopanib | FIMM | pan-cancer | AAC | -0.067 | 0.7 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |